Not applicableAvailableNCT01163383What this trial is testing131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access ProtocolWho this might be right forNeuroblastomaChildhood Metastatic Pheochromocytoma John Maris
Testing effectiveness (Phase 2)Ended earlyNCT01340794What this trial is testingPazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or ParagangliomaWho this might be right forExtra-Adrenal ParagangliomaMetastatic Adrenal Gland PheochromocytomaParaganglioma+1 more National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Study completedNCT01413503What this trial is testingA Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related TumorsWho this might be right forPheochromocytomaParaganglioma University of California, San Francisco 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03839498What this trial is testingStudy of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/ParagangliomaWho this might be right forPheochromocytomaParaganglioma Columbia University 6
Testing effectiveness (Phase 2)Study completedNCT00843037What this trial is testingStudy Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaWho this might be right forParagangliomaPheochromocytoma University Health Network, Toronto 25
Not applicableWithdrawnNCT04770831What this trial is testingPatients Who Receive 131 I-MIBGWho this might be right forBrain and Nervous System Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Ended earlyNCT00466856What this trial is testingInternal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine TumorsWho this might be right forHead and Neck CancerIslet Cell TumorMetastatic Cancer+1 more Vanderbilt-Ingram Cancer Center 10